Key result
Speckle tracking echocardiography and cardiac magnetic resonance with late gadolinium enhancement effectively identify early cardiac impairment and predict the risk of ventricular arrhythmias and sudden cardiac death in patients with Chagas cardiomyopathy.
Why the study?
Different imaging techniques have been tested to assess disease progression and cardiac risk in individuals with Chagas disease, prompting an evaluation of the accuracy of CMR and STE in detecting cardiac complications.
Do cardiac magnetic resonance with late gadolinium enhancement and speckle tracking echocardiography accurately detect cardiac complications in patients with Chagas cardiomyopathy?
Systematic Review (n=1,124)
Do cardiac magnetic resonance with late gadolinium enhancement and speckle tracking echocardiography accurately detect cardiac complications in patients with Chagas cardiomyopathy?
Speckle tracking echocardiography and cardiac magnetic resonance with late gadolinium enhancement are valuable imaging techniques for identifying subclinical heart failure and stratifying the risk of ventricular arrhythmias and sudden cardiac death in patients with Chagas cardiomyopathy.
Supports integration into risk stratification for Chagas cardiomyopathy; extends evidence for advanced imaging beyond standard echocardiography.
Background: Chagas cardiomyopathy (CC) increases cardiovascular mortality associated with congestive heart failure (CHF), ventricular arrhythmias (VA), and sudden cardiac death (SCD). Different imaging techniques have been tested to assess disease progression and cardiac risk in individuals with Chagas disease (ChD). In this systematic review, we evaluated the accuracy in detecting cardiac complications in CC patients using cardiac magnetic resonance (CMR) and speckle tracking echocardiography (STE). Methods: A search was done on PubMed, Cochrane, and Embase for studies in humans over 18 years of age with ChD. Demographic data, research methodology, imaging parameters, and cardiac outcomes were extracted, and study quality was assessed, resulting in a narrative description. Results: Twelve studies with 1124 patients were analyzed. One study discovered a contractility pattern by STE. Four studies assessed the identification of Early Cardiac Impairment (ECI) and VA risk, respectively, while three studies evaluated the risk of SCD. Global Longitudinal Strain (GLS) identified patients with ECI (–18.5 ± 3.4% non-fibrosis vs –14.0 ± 5.8% fibrosis, p = 0.006 and –18 ± 2% non-fibrosis vs –15 ± 2% fibrosis, p = 0.004). The amount of fibrosis >11.78% or in two or more contiguous transmural segments were markers for VA risk. GLS and the amount of fibrosis were found to be predictors of SCD. Conclusions: STE may be considered a screening technique for identifying the subclinical status of CHF. CMR using Late Gadolinium Enhancement (LGE) is considered a relevant parameter for stratifying patients with ChD who are at risk of SCD. Fibrosis and GLS can be used as markers to categorize patients at risk for arrhythmias.
No takes yet. Share an insight, caveat, or question.
Acero et al. (2022) conducted a systematic review in Chagas cardiomyopathy (n=1,124). Cardiac magnetic resonance with late gadolinium enhancement and speckle tracking echocardiography was evaluated on Detection of cardiac complications (congestive heart failure, ventricular arrhythmias, and sudden cardiac death). Speckle tracking echocardiography and cardiac magnetic resonance with late gadolinium enhancement effectively identify early cardiac impairment and predict the risk of ventricular arrhythmias and sudden cardiac death in patients with Chagas cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: